Riskpilot← Back to searchSign inGet full accessDosell AB
ABActiveOrg 5568983018David Bagares Gata 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 20125 employees
Revenue 2024
SEK 7,6M
+513% vs 2023
EBITDA margin
-149.4%
-49% vs 2023
Equity ratio
77.1%
Financial strength
Net profit 2024
SEK -14,1M
-37% vs 2023
| Revenue | SEK 7,6M | +513% |
| EBITDA | SEK -11,4M | -49% |
| Net profit | SEK -14,1M | -37% |
| Total assets | SEK 22,9M | -14% |
| Equity | SEK 17,7M | -15% |
| Employees | 5 | — |
Legal name
Dosell AB
Org number
5568983018
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 juli 2012
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva forskning och utveckling samt kommersialisering av medicinska produkter ävensom idka därmed förenlig verksamhet.
Address
David Bagares Gata 3
Phone
+468211121
Email
info@izafegroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 690 | 442 | 504 | 1 244 | 7 628 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −69 | −2 726 | 2 | −3 | −1 914 | −11 625 | −17 906 | −12 729 | −7 630 | −11 399 |
| Depreciation & amort. | −2 000 | −1 053 | −0 | −0 | −168 | −3 355 | −3 355 | −3 355 | −2 642 | −2 577 |
| EBIT | −2 069 | −3 779 | 2 | −3 | −2 082 | −14 980 | −21 261 | −16 084 | −10 272 | −13 976 |
| Net financials | — | — | — | — | −7 | — | −1 | −25 | −2 | −84 |
| Profit before tax | −2 069 | −193 | 2 | −3 | −2 089 | −14 980 | −21 262 | −16 109 | −10 274 | −14 061 |
| Tax | 438 | 219 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 631 | 26 | 2 | −3 | −2 089 | −14 980 | −21 262 | −16 109 | −10 274 | −14 061 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 032 | 43 | 39 | 39 | 28 594 | 28 773 | 26 551 | 26 321 | 26 822 | 22 934 |
| Equity | 6 200 | 27 | 29 | 26 | 27 936 | 26 956 | 21 694 | 21 175 | 20 901 | 17 683 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 865 | 16 | 10 | 13 | 658 | 1 817 | 4 857 | 5 146 | 5 920 | 5 251 |
| Total debt | 865 | 16 | 10 | 13 | 658 | 1 817 | 4 857 | 5 146 | 5 920 | 5 251 |
EBITDA margin
-149.4%
This company
15.8%
Market median
-1046% vs market
20152024
Equity ratio
77.1%
This company
38.2%
Market median
+102% vs market
20152024
Return on equity
-79.5%
This company
18.4%
Market median
-532% vs market
20152024
Net profit margin
-184.3%
This company
8.1%
Market median
-2375% vs market
20152024
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20152024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JR | Audit | 2021 | — | — |
PJ Audit | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
iZafe Group AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
iZafe Group AB
Dosell AB Board members of Dosell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Richard Kaijser | Audit | 0 companies |
| Per Jonas Eriksson | Audit | 0 companies |
| Bo Göran Torgny Ander | Deputy Board Member | 0 companies |
| Thomas Lars Fredrik Ahlerup | Deputy Board Member | 0 companies |
| Anders Wilhelm Segerström | Board of Directors | 0 companies |
| Richard Egon Wolff | Deputy Board Member | 0 companies |
| Björn Joachim Källsholm | Deputy Board Member | 0 companies |